Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Qi Shen, Zijun Y Xu-Monette, Ganiraju C Manyam, Carlo Visco, Alexandar Tzankov, Xin Cao, Lijuan Deng, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L Richards, Eric D Hsi, William Wl Choi, J Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés Jm FerreriJohn P Farnen, Michael B Møller, Jane N Winter, Miguel A Piris, L Jeffrey Medeiros, Ken H Young

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalBlood
Volume124
Issue number21
ISSN0006-4971
Publication statusPublished - 2014
EventASH Annual Meeting - San Francisco, United States
Duration: 6 Dec 20149 Dec 2014
Conference number: 56th

Conference

ConferenceASH Annual Meeting
Number56th
Country/TerritoryUnited States
CitySan Francisco
Period06/12/201409/12/2014

Cite this